Unnecessary Medication Regimens and Order Administration Errors
Summary
The facility failed to ensure that residents' medication regimens were free from unnecessary medications, including excessive doses or dosages, for 3 of 5 residents reviewed. The report identified that Resident #22, who had diagnoses including Alzheimer's disease with late onset, acute chronic combined systolic heart failure, dementia, hypertension, atrial fibrillation, type 2 diabetes, anemia, and anxiety disorder, had physician orders for DIL-XR 120 mg, 2 capsules daily for hypertension with a hold parameter for SBP below 160, and Metoprolol Succinate ER 25 mg, 3 tablets daily for hypertension with the same hold parameter. The MAR showed DIL-XR was administered on multiple occasions in November 2025 when blood pressures were below 160, including readings such as 131/74, 123/83, 129/80, 131/65, and 131/76, and Metoprolol ER was also administered when the blood pressure was 123/68. Resident #71 had diagnoses including heart failure, muscle weakness, malignant neoplasm of the cecum, hypotension, anemia, chronic kidney disease, anxiety disorder, major depressive disorder, and essential hypertension. The resident had an order for Lisinopril-hydrochlorothiazide 10-12.5 mg daily for hypertension with a hold if SBP was less than 110, and a separate order for Midodrine 5 mg daily for hypotension to be given if BP was below 100/60. The MAR showed Lisinopril-hydrochlorothiazide was administered when the blood pressure was 103/62, and Midodrine was administered when blood pressures were 105/58 and 109/59. During interview, Staff B stated she misinterpreted the order and did administer the medications on those dates. Resident #50 had diagnoses including Parkinson's disease, diabetic neuropathy, hyperglycemia, interstitial pulmonary disease, asthma, long-term anticoagulant use, paroxysmal atrial fibrillation, and hypertension. A pharmacist recommendation dated 1/21/2025 stated Methocarbamol should be reduced to 750 mg daily with the end goal of discontinuation, and the recommendation was accepted and signed by the primary care physician. However, physician orders continued to show Methocarbamol 750 mg twice daily for muscle spasms, and the MAR documented administration twice daily throughout January and February 2025 and for 55 of 60 scheduled doses in November 2025. The DON stated the facility had problems getting pharmacist-recommended changes entered and carried out, and the record review found no progress notes or other documentation addressing why the recommendations had not been followed.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.